Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

Mylan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mylan's 2012 sales performance.

Sandoz joins Europe's MabThera biosimilar push

Sandoz joins Europe's MabThera biosimilar push

Meanwhile, a third biosimilar version of MabThera - from Mylan/Mabion – is scheduled to be filed with the EMA before the end of the year.

WHO pilots scheme to make biosimilars available to poorer countries

WHO pilots scheme to make biosimilars available to poorer countries Meanwhile in the US Mylan recently cut a deal with Roche, which should allow it to launch a biosimilar version of Herceptin in the US ahead of its claimed patent expiry ... The biosimilar -developed by Mylan and partner Biocon - is already available in

Walmsley steps up to chief executive role at GSK

Walmsley steps up to chief executive role at GSK The new CEO has been given an early gift as she steps into the role by the FDA, which just rejected Mylan's application to market a generic version of

Mylan deal with Roche clears path to biosimilar Herceptin launch

Mylan deal with Roche clears path to biosimilar Herceptin launch Mylan deal with Roche clears path to biosimilar Herceptin launch. Covers global markets with the exception of Japan, Brazil and Mexico. ... After months of wrangling in the courts, Mylan and Roche have agreed a licensing deal that should allow a

2016: The year when deal-makers took stock?

2016: The year when deal-makers took stock? Fewer NCEs coming through. Politics and pricing certainly had an impact, with the US backlash against aggressive pharma pricing following Mylan's EpiPen debacle, itself coming on the heels of the

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Launch Sequencing Case Study
...
Rapid Payer Response Early Pipeline Case Study
...
How can pharma help the NHS capitalise on its data?
Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services...

Infographics